John Turnidge

24.9k total citations · 5 hit papers
264 papers, 17.3k citations indexed

About

John Turnidge is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, John Turnidge has authored 264 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Infectious Diseases, 101 papers in Molecular Medicine and 99 papers in Epidemiology. Recurrent topics in John Turnidge's work include Antibiotic Resistance in Bacteria (101 papers), Antimicrobial Resistance in Staphylococcus (80 papers) and Bacterial Identification and Susceptibility Testing (77 papers). John Turnidge is often cited by papers focused on Antibiotic Resistance in Bacteria (101 papers), Antimicrobial Resistance in Staphylococcus (80 papers) and Bacterial Identification and Susceptibility Testing (77 papers). John Turnidge collaborates with scholars based in Australia, United States and United Kingdom. John Turnidge's co-authors include Jan Bell, Roger L. Nation, Jian Li, Kingsley Coulthard, Robert Milne, David L. Paterson, Ronald N. Jones, Michael A. Pfaller, Gunnar Kahlmeter and Craig R. Rayner and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

John Turnidge

257 papers receiving 16.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

2006 1.1k citations Jian Li, Roger L. Nation et al. profile →
Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community

2002 755 citations John Turnidge, Jan Bell et al. profile →
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model

1988 595 citations John Turnidge et al. profile →
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

2019 562 citations Michael A. Pfaller, John Turnidge et al. profile →
The Pharmacodynamics of β‐Lactams

1998 492 citations John Turnidge profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Turnidge Australia	71	7.1k	6.3k	6.0k	5.8k	3.5k	264	17.3k
George G. Zhanel Canada	69	8.0k 1.1×	3.8k 0.6×	5.8k 1.0×	7.4k 1.3×	2.0k 0.6×	444	18.5k
James A. Karlowsky Canada	66	8.3k 1.2×	3.4k 0.5×	5.5k 0.9×	6.2k 1.1×	2.5k 0.7×	326	15.1k
Keith S. Kaye United States	75	8.6k 1.2×	4.5k 0.7×	5.1k 0.9×	5.7k 1.0×	3.5k 1.0×	417	20.1k
Johan W. Mouton Netherlands	71	5.5k 0.8×	6.1k 1.0×	7.3k 1.2×	8.1k 1.4×	2.0k 0.6×	353	18.6k
Daniel F. Sahm United States	66	7.7k 1.1×	3.1k 0.5×	4.6k 0.8×	4.4k 0.8×	2.4k 0.7×	270	13.5k
Matteo Bassetti Italy	73	7.0k 1.0×	6.8k 1.1×	5.2k 0.9×	7.3k 1.3×	2.7k 0.8×	574	19.5k
Hélio S. Sader United States	77	11.2k 1.6×	8.3k 1.3×	6.9k 1.1×	6.5k 1.1×	5.1k 1.5×	613	22.2k
Robert K. Flamm United States	61	6.1k 0.9×	3.6k 0.6×	4.2k 0.7×	3.7k 0.6×	1.9k 0.5×	338	11.6k
Mariana Castanheira United States	72	9.1k 1.3×	8.1k 1.3×	5.0k 0.8×	7.8k 1.4×	2.1k 0.6×	424	18.5k
Gunnar Kahlmeter Sweden	54	10.7k 1.5×	4.4k 0.7×	3.5k 0.6×	6.3k 1.1×	3.7k 1.1×	204	21.4k

Countries citing papers authored by John Turnidge

Since Specialization

Citations

This map shows the geographic impact of John Turnidge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Turnidge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Turnidge more than expected).

Fields of papers citing papers by John Turnidge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Turnidge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Turnidge. The network helps show where John Turnidge may publish in the future.

Co-authorship network of co-authors of John Turnidge

This figure shows the co-authorship network connecting the top 25 collaborators of John Turnidge. A scholar is included among the top collaborators of John Turnidge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Turnidge. John Turnidge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turnidge, John, Sören Gatermann, Gunnar Kahlmeter, et al.. (2025). Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review. SHILAP Revista de lepidopterología. 2(2). 105082–105082. 4 indexed citations

Ashcroft, Melinda M., Michelle J. Bauer, Jan Bell, et al.. (2024). The complete genome sequence of five pre-2013 Escherichia coli sequence type (ST)1193 strains reveals insights into an emerging pathogen. Access Microbiology. 6(10). 1 indexed citations

Turnidge, John, et al.. (2022). Development of Quality Control Ranges for Biocide Susceptibility Testing. Pathogens. 11(2). 223–223. 5 indexed citations

Abraham, Rebecca, Mark O’Dea, Terence Lee, et al.. (2021). Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance. Journal of Antimicrobial Chemotherapy. 76(7). 1800–1807. 12 indexed citations

Kluytmans, Jan, Christian G. Giske, Alasdair MacGowan, et al.. (2019). Obituary: Johan Willem Mouton. Clinical Microbiology and Infection. 26(1). 125–126. 1 indexed citations

Turnidge, John, et al.. (2019). Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patients. Australian Health Review. 44(2). 263–269.

Lappin, Michael R., D.M. Boothe, Edward B. Breitschwerdt, et al.. (2017). Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases. Journal of Veterinary Internal Medicine. 31(2). 279–294. 191 indexed citations

Lin, Yu-Wei, Qi Zhou, Mei‐Ling Han, et al.. (2017). Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model. Antimicrobial Agents and Chemotherapy. 62(2). 15 indexed citations

Espinel‐Ingroff, Ana, Maiken Cavling Arendrup, Rafael Cantón, et al.. (2016). Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method. Antimicrobial Agents and Chemotherapy. 61(1). 76 indexed citations

10.

Colombo, Arnaldo Lopes, Susana Córdoba, Philippe J. Dufresne, et al.. (2015). International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. Antimicrobial Agents and Chemotherapy. 60(2). 1079–1084. 121 indexed citations

11.

Lubbers, Brian V. & John Turnidge. (2014). Antimicrobial susceptibility testing for bovine respiratory disease: Getting more from diagnostic results. The Veterinary Journal. 203(2). 149–154. 29 indexed citations

12.

Holmes, Natasha E., John Turnidge, Wendy Munckhof, et al.. (2013). Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection. 19(12). 1163–1168. 18 indexed citations

13.

Gordon, Claire L., et al.. (2012). Trough Concentrations of Vancomycin. The Pediatric Infectious Disease Journal. 31(12). 1269–1271. 42 indexed citations

14.

Mouton, Johan W., Paul G. Ambrose, Rafael Cantón, et al.. (2011). Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resistance Updates. 14(2). 107–117. 156 indexed citations

15.

Turnidge, John, et al.. (2010). fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. Journal of Antimicrobial Chemotherapy. 65(9). 1984–1990. 138 indexed citations

16.

Munckhof, Wendy, et al.. (2004). Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study. International Journal of Antimicrobial Agents. 24(6). 605–608. 19 indexed citations

17.

Nimmo, Graeme R., Jan Bell, David Mitchell, et al.. (2003). Antimicrobial Resistance in Staphylococcus aureus in Australian Teaching Hospitals, 1989-1999. Microbial Drug Resistance. 9(2). 155–160. 61 indexed citations

18.

Bell, Jan, John Turnidge, Michael A. Pfaller, & Ronald N. Jones. (2002). In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998–1999). Diagnostic Microbiology and Infectious Disease. 43(4). 315–318. 4 indexed citations

19.

Turnidge, John & Jan Bell. (2000). Methicillin-Resistant Staphylococcal aureus Evolution in Australia Over 35 Years JOHN D. TURNIDGE and JAN M. BELL. Microbial Drug Resistance. 6(3). 223–229. 42 indexed citations

20.

Leder, Karin, John Turnidge, Tony M. Korman, & M. Lindsay Grayson. (1999). The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. Journal of Antimicrobial Chemotherapy. 43(1). 113–118. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact